MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
Feb 19, 04:59 PM (EDT)
Price
$83.35
Change
+$1.02 (+1.24%)
Capitalization
366.23B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NVO with price predictions
Feb 19, 2025

NVO sees its Stochastic Oscillator recovers from oversold territory

On February 19, 2025, the Stochastic Oscillator for NVO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVO's RSI Indicator exited the oversold zone, of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 19, 2025. You may want to consider a long position or call options on NVO as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NVO just turned positive on February 18, 2025. Looking at past instances where NVO's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVO entered a downward trend on January 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.349) is normal, around the industry mean (12.603). P/E Ratio (26.221) is within average values for comparable stocks, (85.841). Projected Growth (PEG Ratio) (1.200) is also within normal values, averaging (1.584). Dividend Yield (0.017) settles around the average of (0.013) among similar stocks. P/S Ratio (9.116) is also within normal values, averaging (253.013).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NVO is expected to report earnings to fall 85.68% to 90 cents per share on May 07

Novo-Nordisk A/S NVO Stock Earnings Reports
Q1'25
Est.
$0.91
Q4'24
Beat
by $5.46
Q3'24
Beat
by $5.24
Q2'24
Beat
by $9.46
Q1'24
Beat
by $4.93
The last earnings report on February 05 showed earnings per share of $6.34, beating the estimate of 87 cents. With 5.95M shares outstanding, the current market capitalization sits at 366.23B.
A.I.Advisor
published Dividends

NVO paid dividends on August 26, 2024

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $0.52 per share was paid with a record date of August 26, 2024, and an ex-dividend date of August 16, 2024. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMFC12.020.16
+1.35%
New Mountain Finance Corp
OPXS6.040.06
+1.00%
Optex Systems Holdings
IMMP2.02-0.02
-0.98%
Immutep Limited
LEN120.94-1.56
-1.27%
Lennar Corp
LU2.85-0.07
-2.40%
Lufax Holding Ltd

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+1.30%
NONOF - NVO
70%
Closely correlated
+0.98%
GALT - NVO
35%
Loosely correlated
-0.65%
BCAB - NVO
31%
Poorly correlated
N/A
CRBP - NVO
30%
Poorly correlated
-4.99%
AXON - NVO
29%
Poorly correlated
-16.42%
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+1.30%
Pharmaceuticals
category (303 stocks)
44%
Loosely correlated
+53.94%